Aktis Oncology (AKTS) Q4 2023 Earnings

13FebConfirmed
Q1 2023
Q2 2023
Q3 2023
Q4 2023
-0.26
-0.23
-0.2
-0.17

Details

Expected EPS
-0.18
Actual EPS
-0.19
Surprise EPS
-0.01
Surprise Percent
+5.56%

Description

Aktis Oncology (AKTS) has reported earnings of -0.19 per share for Q4 2023.

0 Comments

Share your thoughts